Cefpirome and continuous venovenous hemofiltration

被引：0
|
作者：
F. Thalhammer
P. Siostrzonek
机构：
[1] Department of Internal Medicine I,
[2] Division of Infectious Diseases,undefined
[3] University of Vienna,undefined
[4] Währinger Gürtel 18–20,undefined
[5] 1090 Vienna,undefined
[6] Austria e-mail: florian.thalhammer@akh-wien. ac.at Tel.: + 43-1-4 04 00 44 40 Fax: + 49-89-2 44 31 86 96,undefined
[7] Department of Cardiology,undefined
[8] Intensive Care Unit,undefined
[9] University of Vienna,undefined
[10] Währinger Gürtel 18–20,undefined
[11] 1090 Vienna,undefined
[12] Austria,undefined
来源：
Intensive Care Medicine | 2000年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：830 / 830
相关论文
共 50 条
  • [1] Cefpirome and continuous venovenous hemofiltration
    Thalhammer, F
    Siostrzonek, P
    [J]. INTENSIVE CARE MEDICINE, 2000, 26 (06) : 830 - 830
  • [2] Cefpirome and continuous venovenous hemofiltration
    T. S. van der Werf
    C. A. Stegeman
    [J]. Intensive Care Medicine, 2000, 26 (6) : 831 - 831
  • [3] CONTINUOUS VENOVENOUS HEMOFILTRATION
    YORGIN, PD
    KRENSKY, AM
    TUNE, BM
    [J]. PEDIATRIC NEPHROLOGY, 1990, 4 (06) : 640 - 642
  • [4] Pharmacokinetics of cefpirome during continuous venovenous hemofiltration:: Rationale for an 8-hour dosing interval
    Banyai, M
    Thalhammer, F
    El Menyawi, I
    Heinz, G
    Traunmüller, F
    Siostrzonek, P
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (04) : 368 - 372
  • [5] LIDOCAINE IN CONTINUOUS VENOVENOUS HEMOFILTRATION
    BRIERTON, DG
    MUELLER, BA
    SCARIM, SK
    MACIAS, WL
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (10) : 1498 - 1499
  • [6] Linezolid and continuous venovenous hemofiltration
    Meyer, B
    Thalhammer, F
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (03) : 435 - 436
  • [7] Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis
    Matzke, GR
    Frye, RF
    Joy, MS
    Palevsky, PM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) : 1639 - 1644
  • [8] Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis
    Joy, MS
    Matzke, GR
    Frye, RF
    Palevsky, PM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (06) : 1019 - 1027
  • [9] Influence of Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodiafiltration on the Disposition of Doripenem
    Cirillo, Iolanda
    Vaccaro, Nicole
    Balis, Dainius
    Redman, Rebecca
    Matzke, Gary R.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (03) : 1187 - 1193
  • [10] Phenytoin Removal by Continuous Venovenous Hemofiltration
    Oltrogge, Kate M.
    Peppard, William J.
    Saleh, Mohammed
    Regner, Kevin R.
    Herrmann, David J.
    [J]. ANNALS OF PHARMACOTHERAPY, 2013, 47 (09) : 1218 - 1222
12345